Aktuell 17. Mai 2024 Vierländerregion Bodensee treibt Innovation voran Der Wissenschaftsverbund Vierländerregion Bodensee (W4) treibt zielgerichtet Innovation in Wissenschaft, Wirtschaft und Gesellschaft an. Im erste...
News 17. Mai 2024 Lake Constance four-country region promotes innovation The Lake Constance Arts & Sciences Association (W4) is taking a targeted approach to expediting scientific, business and social innovation. In it...
Actualités 30. Apr. 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 06. Nov. 2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
News 06. Dez. 2023 EPFL’s new AI Center to pioneer AI research and collaboration in Switzerland The Ecole Polytechnique Fédérale de Lausanne (EPFL) has launched its new AI Center. This new hub is dedicated to exploring how safe and effective...
Aktuell 06. Mai 2024 EY meldet Plus von 53 Prozent bei Investitionen in der Schweiz Ausländische Investitionen in Europa sind 2023 um 4 Prozent gesunken. Die Investitionen in der Schweiz sind dagegen um 53 Prozent gestiegen. Das ...
Actualités 06. Nov. 2023 LAGOSTA et le géant mondial Merck collaborent pour la distribution de chitosan La société biotechnologique LAGOSTA a annoncé une collaboration avec Merck. Ce partenariat vise à faciliter la distribution du chitosan de qualit...
News 03. Nov. 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 17. Apr. 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 09. Aug. 2023 Bühler collaborating with Ikawa for coffee roasting The technology company Bühler from the canton of St.Gallen has entered into a strategic partnership with Ikawa, the British manufacturer of coffe...
Actualités 23. Aug. 2023 Click Analytic lève USD 600’000 pour repenser le marketing d’influence La start-up genevoise Click Analytic a annoncé la clôture réussie de son tour de financement préliminaire, levant USD 600’000 auprès d'un mélange...
News 06. Mai 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
Actualités 03. Nov. 2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
News 03. Mai 2024 QS lists half of Swiss subjects in global top 100 Only the USA and the UK rank higher than Switzerland in the QS World University Rankings 2024 for subjects listed in the top 10 worldwide. It's a...
News 29. Febr. 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 09. Apr. 2024 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
Actualités 17. Apr. 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...